Fagron is committed to ensuring proper corporate governance. As a global company with the ambition to create the future of personalized medicine, we believe that all our products should be produced responsibly.

We adhere to the applicable laws and regulations in all countries in which we operate. Fagron's Global Policies reflect the general principles of how we conduct our business:

Global Anti-Bribery & Anti-Corruption Policy

Global Human Rights Policy

Modern Slavery Statement

Fagron Business Partner Code of Conduct 2021

ESG Strategy 2021

Fagron Carbon Footprint 2019 and 2020

Remuneration policy 2021

Governance Documents

Articles of association Fagron, 7 July 2016 (Dutch only),

Download Articles of association
 

On 4 October 2007, the Board of Directors adopted the Corporate Governance Charter. The current version was adopted by the Board of Directors on 6 February 2017.

Corporate governance charter

Annex 1 Terms of reference

Annex 2 Transactions policy

Annex 3 Prevention of inside information and market abuse

Annex 4 Audit committee

Annex 5 Nomination and remuneration committee

Annex 6 Executive committee